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Multiplex molecular panels are relentlessly replacing conventional methods for the detection
of enteric pathogens from stool samples in clinical and research laboratories. Here we eval-
uated four commercial multiplex real-time PCR assays for the detection of Cryptosporidium
hominis/parvum, Giardia duodenalis and Entamoeba histolytica.
Methods
The diagnostic performance of the Gastroenteritis/Parasite Panel I (Diagenode), the RIDA-
GENE Parasitic Stool Panel (R-Biopharm), the Allplex Gastrointestinal Parasite Panel 4
(Seegene) and the FTD Stool Parasites (Fast Track) real-time PCR methods was assessed
against a reference panel of 126 well-characterized DNA samples including Cryptosporid-
ium hominis (n = 29), Cryptosporidium parvum (n = 3), Giardia duodenalis (n = 47), Ent-
amoeba histolytica (n = 3), other parasite species (n = 20), and apparently healthy subjects
(n = 24).
Principal findings
Obtained diagnostic sensitivities ranged from 53–88% for Cryptosporidium hominis/parvum,
and from 68–100% for G. duodenalis. The R-Biopharm method achieved the best perfor-
mance for the detection of Cryptosporidium hominis/parvum both in terms of diagnostic sen-
sitivity (87.5%) and detection limit (a 100-fold increase compared to other tests). The Fast
Track method was particularly suited for the detection of G. duodenalis, achieving a 100%
sensitivity and a detection limit at least 10-fold superior. Detection of E. histolytica was simi-
larly achieved by all compared methods except Diagenode.
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Conclusions
Diagnostic performance varied largely depending on the method used and the targeted
pathogen species. Factors including test sensitivity/specificity, cost, patient population sur-
veyed, laboratory workflow, and diagnostic algorithm should be carefully considered when
choosing the most appropriate multiplex PCR platform.
Introduction
Enteric Giardia duodenalis, Cryptosporidium spp., and Entamoeba histolytica are the most
important diarrhoea-causing protozoa globally. Infections by these parasites cause significant
morbidity and mortality primarily among children living in resource-poor settings in develop-
ing countries [1], but are also a significant public health concern in developed nations [2].
Indeed, these three protozoan species account for up to 70% of the gastrointestinal parasites
diagnosed every year at hospital-based microbiology laboratories in Europe [3]. Additionally,
both G. duodenalis and Cryptosporidium spp. are increasingly recognized as important water-
borne and foodborne pathogens all over the world [4–6].
Light microscopy stands as the preferred routine diagnosis method for enteric protozoan
parasites in most clinical settings. Although this technique is labour-intensive, lacks sensitivity,
and requires skilled technicians, its simplicity and low cost outweighs the above mentioned
limitations and makes microscopy suited for resource-limited laboratories particularly in
endemic, high-prevalence areas. However, in high-income countries where parasite prevalence
rates and burden are typically low and diagnostic sensitivity become an issue, a different diag-
nostic approach is clearly needed [7,8]. Other pressing issues include growing costs of labour,
increased sample testing, a desire for improved throughput, and optimized laboratory work-
flows. All together, these facts explain why microscopy is being progressively replaced by
highly sensitive DNA-based assays as first-line routine diagnostic methods for intestinal para-
sites in many clinical settings in western countries, mainly in Europe [8,9].
In recent years a wide diversity of in-house real-time PCR (qPCR) assays have been devel-
oped for detecting enteric viral, bacterial and parasitic, diarrhoea-causing, agents, with the
trend fast moving from single pathogen detection to a multiplex approach allowing simulta-
neous identification of multiple pathogens [10,11]. An additional advantage of this technology
is that it can be easily adapted to specific diagnostic requirements (e.g. pathogen combina-
tions) depending on the population or patient group under study. Currently, several multiplex
gastrointestinal pathogen panel tests are commercially available, including fully integrated
robotic systems incorporating DNA extraction, amplification, detection, and analysis directly
from stool samples [9,12]. A number of these methods (e.g. BD MAX Enteric Parasite Panel,
Dickinson and Company, USA; Luminex xTAG Gastrointestinal Pathogen Panel, Luminex
Corporation, Canada; NanoCHIP GIP, Savyon Diagnostics Ltd, Israel) have received clearance
from public health agencies like the U.S. Food and Drug Administration (USA) and are being
progressively incorporated in the diagnostic algorithms of modern clinical laboratories, partic-
ularly those attending large populations of paediatric, immunocompromised, or returning
traveller populations [9]. Of notice, most of the studies conducted to evaluate the diagnostic
performance of these and similar methods were based on prospectively and/or retrospectively
collected stool samples with a previous diagnosis by microscopy examination [13–19]. In addi-
tion, a recent inter-laboratory external quality assessment scheme has evidenced the need of
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harmonization of molecular-based protocols and procedures for the detection of enteric proto-
zoa within the European Union [20].
Here we aimed to evaluate the diagnostic sensitivity and specificity of four commercial mul-
tiplex qPCR assay for the specific detection of Cryptosporidium hominis/parvum, Giardia duo-
denalis and Entamoeba histolytica. The study was conducted against a reference panel of DNA
samples extracted from stool specimens.
Materials and methods
Ethics statement
The study design and consent procedures involved in this survey have been approved by the
Research Ethics Committee of the Carlos III Health Institute under reference number CEI PI
17_2017-v3. Written informed consent was not required for this study because the stool sam-
ples used were exclusively intended for routine clinical diagnostic procedures. All samples
were anonymized using a unique laboratory identifier code to guarantee the anonymity and
confidentiality of the patients.
DNA reference panel
A total of 126 well-characterised DNA samples extracted and purified from stool specimens
of clinically confirmed patients were obtained from a previously published study by our labo-
ratory [21]. These included PCR-positive samples for Cryptosporidium hominis (n = 29), C.
parvum (n = 3), Giardia duodenalis (n = 47), and Entamoeba histolytica (n = 3). No Cryptospo-
ridium species other than C. hominis and C. parvum were assessed. Potential cross-reactivity
was assessed against DNA samples positive for E. dispar (n = 10), Leishmania infantum (n = 2),
Trypanosoma cruzi (n = 2), Toxoplasma gondii (n = 2), Ascaris lumbricoides (n = 3), Strongy-
loides stercoralis (n = 1), and apparently healthy subjects (n = 24) with a negative result for
Cryptosporidium hominis/parvum, G. duodenalis and E. histolytica/dispar by PCR. Four ali-
quots of each individual DNA sample were prepared and stored at –20˚C until tested with
each assay to prevent degradation by freeze-thawing. The full dataset showing the characteris-
tics of the DNA sample panel used and the diagnostic results obtained with each method is
shown in S1 Table.
Multiplex real-time PCR assays
The four commercial multiplex real-time PCR (qPCR) assays compared here were the Gastro-
enteritis/Parasite Panel I (Diagenode, Seraing, Belgium), the RIDAGENE Parasitic Stool Panel
(R-Biopharm, Darmstadt, Germany), the Allplex Gastrointestinal Parasite Panel 4 (Seegene,
Seoul, Korea), and the FTD Stool Parasites (Fast Track Diagnostics, Luxembourgh). The main
features of these assays, including previously reported diagnostic sensitivity and specificity val-
ues, are shown in Table 1.
In an attempt to normalise initial experimental conditions among assays, DNA samples
(5 μL for all methods excepting the FTD Stool Parasites method, for which 10 μL were used fol-
lowing the manufacturer´s recommendation) were tested undiluted in a 25 μL final volume.
No sample duplicates were carried out. In the case of PCR inhibition, the sample was diluted
10-fold and retested. Experiments were performed on a Corbett Rotor-Gene 6000 qPCR cycler
(Qiagen Corbett, Hilden, Germany) except otherwise indicated. All four methods included
appropriate negative, positive, and qPCR inhibition controls. Multiplex qPCR protocols were
conducted in strict accordance with the manufacturer´s instructions with few modifications as
follows:
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1. RIDAGENE Parasitic Stool Panel (R-Biopharm). Amplification reactions were conducted
on an Mx3005P qPCR instrument (Agilent Technologies, Waldbronn, Germany) provided
by the manufacturer as the method was not yet fully validated for the Rotor-Gene 6000
qPCR system at the time of the analyses.
2. Allplex Gastrointestinal Parasite Panel 4 (Seegene). This method includes an automated
DNA extraction system that was not used in the present study for comparative reasons.
Amplification reactions were carried out on the CFX96 qPCR instrument (Bio-Rad Labora-
tories, CA, USA) provided by the manufacturer.
Simulated mixed infections
To mimic natural co-infections involving double (Cryptosporidium + Giardia) and triple
(Cryptosporidium + Giardia + E. histolytica or E. dispar) pathogen combinations a total of 10
different simulated mixes were artificially generated. Each combination was prepared by mix-
ing equal amounts of individual DNA samples from the reference panel (S1 Table). Simulated
mixed infections were also used to indirectly assess diagnostic sensitivities and specificities of
each method.
Relative detection limit
Ten-fold serial dilutions of individual Cryptosporidium (undiluted to 10−3) and Giardia (10−1
to 10−4) positive DNA samples from the reference panel were tested in each compared method
for detection limit determination based on cycle threshold (Ct) values obtained during qPCR.
This assessment was not conducted for E. histolytica due to the low number of samples avail-
able and the high Ct values associated to them.
Data analyses
The Shapiro-Wilk’s test was used to assess the normality of distribution of the Ct values
obtained in Cryptosporidium- and Giardia-positive samples during qPCR analyses with each
method evaluated. Once normality was demonstrated, an analysis of variance (ANOVA) for
simultaneous comparison of methods was conducted. A probability (P) value< 0.05 was con-
sidered evidence of statistical significance. Statistical analyses were performed using the soft-
ware package SPSS version 21.0 (IBM Corp., USA).
Table 1. Main features and reported diagnostic performance of the four commercial multiplex real-time PCR assays compared in the present study for the detec-
tion of Cryptosporidium hominis/parvum, Giardia duodenalis, and Entamoeba histolytica from clinical DNA samples.
Method Manufacturer Automated DNA extraction Sensitivity (%) Specificity (%) References
Gastroenteritis/Parasite Panel I Diagenode No 92–100 100 [3,15]
RIDAGENE Parasitic Stool Panel R-Biopharm No 95–100a 99–100a –
Allplex Gastrointestinal Parasite Panel 4 Seegene Yes NS NS –
FTD Stool Parasites Fast Track No NS NS [13]
Notes: the RIDAGENE Parasitic Stool Panel (R-Biopharm) is designed to also detect Dientamoeba fragilis. The Allplex Gastrointestinal Parasite Panel 4 (Seegene) is
designed to also detect Blastocystis hominis, Dientamoeba fragilis, and Cyclospora cayetanensis.
NS: not specified.
a As reported by the manufacturer.
https://doi.org/10.1371/journal.pone.0215068.t001
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Results
The diagnostic performance results of the four multiplex qPCR methods compared here are
summarized in Table 2. The R-Biopharm method was the most sensitive (87.5%) assay for the
detection of Cryptosporidium hominis/parvum, with the Fast Track assay performing poorly
(53.1%). All four methods detected the three C. parvum DNA samples assessed. When tested
undiluted, Cryptosporidium-positive DNA samples generated an elevated number of inhibitory
reactions mostly resolved when re-tested in a 1:10 dilution. This was particularly true for the
R-Biopharm and the Diagenode methods (of note, the former manufacturer specifically rec-
ommends diluting faecal suspensions 1:3 prior to DNA extraction). This issue was observed
neither for Giardia- nor Entamoeba-positive DNA samples. One-way ANOVA test results
showed significant (P< 0.05) variations in the distribution of obtained Ct values among the
four multiplex qPCR methods assessed here, although no one-by-one direct comparison of
methods was attempted due to unsurmountable differences in equipment (e.g. thermocycler
used) features and assay (e.g. initial volume of DNA tested) procedures. In line with the find-
ings mentioned above, the R-Biopharm method produced lower mean Ct values either in
unpaired (mean: 30.1; 95% CI: 28.6–31.5) (Fig 1A) and paired (mean: 28.2; 95% CI: 26.9–29.6)
(Fig 1B) Cryptosporidium-positive DNA samples than the other three methods tested.
Regarding G. duodenalis, the Fast Track method showed a 100% sensitivity, closely followed
by the Seegene assay (91.5%). The latter method also detected all three E. histolytica positive
samples, whereas the R-Biopharm and Fast Track produced a positive result for two out of
these three samples. When Ct values for G. duodenalis-positive samples were plotted, the Fast
Track method generated the lowest figures either in unpaired (mean: 26.6; 95% CI: 25.5–27.8)
(Fig 2A) and paired (mean: 25.2; 95% CI: 23.7–26.8) (Fig 2B) sample groups. Very similar
results were obtained with the Diagenode assay. No obvious association between Giardia-neg-
ative samples by the Diagenode, R-Biopharm, and Seegene methods and the magnitude of the
qPCR Ct values at initial diagnosis (ranging from 20.7 to 32.8) was observed (S1 Table).
Table 2. Diagnostic performance of the four commercial multiplex real-time PCR assays compared in the present study for the detection of Cryptosporidium homi-
nis/parvum, Giardia duodenalis, and Entamoeba histolytica using a reference panel of well-characterized DNA samples (n = 126) from clinical specimens and
healthy subjects.
Diagenode R-Biopharm Seegene Fast Track
Protozoan pathogen Samples (n) + % + % + % + %
Cryptosporidium spp. 32 24 75.0 28 87.5 25 78.1 17 53.1
C. hominis 29 21 72.4 25 86.2 22 75.9 14 48.3
C. parvum 3 3 100 3 100 3 100 3 100
Giardia duodenalis 47 32 68.1 37 78.7 43 91.5 47 100
Entamoeba histolytica 3 0 0.0 2 66.7 3 100 2 66.7
Other parasite species 20 0 0.0 0 0.0 0 0.0 0 0.0
Entamoeba dispar 10 0 0.0 0 0.0 0 0.0 0 0.0
Leishmania infantum 2 0 0.0 0 0.0 0 0.0 0 0.0
Trypanosoma cruzi 2 0 0.0 0 0.0 0 0.0 0 0.0
Toxoplasma gondii 2 0 0.0 0 0.0 0 0.0 0 0.0
Ascaris lumbricoides 3 0 0.0 0 0.0 0 0.0 0 0.0
Strongyloides stercoralis 1 0 0.0 0 0.0 0 0.0 0 0.0
Healthy subjects 24 0a 0.0 1b 4.2 1c 4.2 ND ND
Notes: ´+´ refers to positive detection, ND stands for ´not determined´.
a Only 13/24 samples tested.
b Sample positive to G. duodenalis with a Ct value = 37.73.
c Sample positive to Cryptosporidium hominis/parvum. with a Ct value = 40.20.
https://doi.org/10.1371/journal.pone.0215068.t002
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No non-specific amplification/cross-reactivity was seen in any of the four multiplex qPCR
methods when DNA samples from other parasitic/commensal species (E. dispar, L. infantum,
T. cruzi, T. gondii, A. lumbricoides and S. stercoralis) were tested. All 24 DNA samples from
apparently healthy subjects tested negative, excepting one sample that was G. duodenalis-posi-
tive by R-Biopharm (Ct = 37.7) and a sample that was Cryptosporidium-positive by Seegene
(Ct = 40.2). A number of previously unnoticed co-infections were observed within the panels
of selected DNA samples positive for Cryptosporidium hominis/parvum, G. duodenalis and E.
histolytica/dispar, most of them associated with high (� 35) Ct values (S1 Table). This finding
is most likely due to the comparatively higher detection sensitivity of the multiplex qPCR
methods with those of the conventional PCRs used in the primary diagnosis of the samples,
although the occurrence of false-positive results could not be completely ruled out.
Testing of artificially-prepared mixed infections showed that, overall, the R-Biopharm
method delivered the most consistent diagnostic results (Table 3). This method detected Cryp-
tosporidium hominis/parvum in all simulated mixed infections except one, with lower Ct val-
ues than those obtained by the other three assays. Both the R-Biopharm and the Diagenode
methods were also the only procedures able to detect G. duodenalis in all 10 mixed combina-
tions assessed, even considering that the Fast Track system typically generated lower Ct values
for this particular species. Additionally, detection of E. histolytica was only achieved by the
R-Biopharm and the Fast Track methods in two out of the three samples tested, the latter assay
showing the lowest Ct values.
Fig 1. Dotplot showing the distribution of Ct values for Cryptosporidium-positive DNA samples obtained with
each of the four commercial multiplex real-time PCR assays evaluated in this study. Mean values and standard
deviation ranges for each group are represented by large and short horizontal bars, respectively. Unpaired (panel A)
and paired (panel B) groups were represented for comparative purposes.
https://doi.org/10.1371/journal.pone.0215068.g001
Fig 2. Dotplot showing the distribution of Ct values for G. duodenalis-positive DNA samples obtained with each
of the four commercial multiplex real-time PCR assays evaluated in this study. Mean values and standard deviation
ranges for each group are represented by large and short horizontal bars, respectively. Unpaired (panel A) and paired
(panel B) groups were represented for comparative purposes.
https://doi.org/10.1371/journal.pone.0215068.g002
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Confirming previous diagnostic findings, relative detection limit analyses based on serial
dilutions of one sample positive for Cryptosporidium and one sample positive for G. duodenalis
demonstrated that the R-Biopharm method was two order of magnitude more sensitive for the
detection of Cryptosporidium than the other three assays evaluated (Fig 3A). For the detection
of G. duodenalis, the best performance was achieved by the Fast Track method, at least one
order of magnitude more sensitive than that of the other assays (Fig 3B).
Discussion
In this comparative study we evaluated four commercial multiplex qPCR methods for the
identification of the three most clinically relevant protozoan enteric parasites, namely Crypto-
sporidium spp., Giardia duodenalis, and Entamoeba histolytica. The diagnostic performance of
both the Diagenode and the Fast Track assays have been individually assessed and compared
to that obtained by microscopy in previous studies [3,13,15]. However, this is the first compre-
hensive survey reporting the diagnostic performance of the R-Biopharm and Seegene methods.
Table 3. Diagnostic performance of the four commercial multiplex real-time PCR assays compared in the present study for the detection of Cryptosporidium homi-
nis, Giardia duodenalis, and Entamoeba histolytica in artificially prepared DNA samples mimicking mixed infections. Cycle-threshold values are shown.
Cryptosporidium hominis Giardia duodenalis Entamoeba histolytica
Combination Diagenode R-Biopharm Seegene Fast
Track
Diagenode R-Biopharm Seegene Fast
Track
Diagenode R-Biopharm Seegene Fast
Track
1: Cr + G
+ Eh
28.9 28.9 30.3 33.5 32.0 38.7 39.1 30.2 Neg. 41.8 Neg. 30.4
2: Cr + G
+ Eh
38.6 31.3 34.4 Neg. 20.9 25.7 25.0 19.4 Neg. 38.7 Neg. 33.4
3: Cr + G
+ Eh
Neg. Neg. Neg. Neg. 24.9 29.5 28.2 23.7 Neg. Neg. Neg. Neg.
4: Cr + G
+ Ed
37.6 29.1 33.4 Neg. 28.4 31.8 33.9 Neg. – – – –
5: Cr + G 26.7 25.9 27.0 34.2 23.8 27.8 27.7 29.4 – – – –
6: Cr + G 28.0 27.5 28.6 Neg. 25.5 29.8 29.8 19.4 – – – –
7: Cr + G 40.9 30.5 34.3 Neg. 31.5 32.6 Neg. 23.7 – – – –
8: Cr + G Neg. 37.7 Neg. Neg. 26.8 29.6 30.1 26.8 – – – –
9: Cr + G Neg. 29.7 32.6 Neg. 32.5 39.1 38.3 21.9 – – – –
10: Cr + G 39.9 30.6 34.0 Neg. 27.6 32.3 31.9 24.9 – – – –
Notes: ´Neg.´ refers to a negative detection in the presence of parasitic DNA; ´–´ refers to a negative detection in the absence of parasitic DNA; Cr, Cryptosporidium
hominis; G, Giardia duodenalis; Eh, Entamoeba histolytica; Ed, Entamoeba dispar.
https://doi.org/10.1371/journal.pone.0215068.t003
Fig 3. Relative detection limit analyses of the four commercial multiplex real-time PCR assays evaluated in this
comparative study using serial dilutions of Cryptosporidium-positive (panel A) and Giardia-positive (panel B)
individual DNA samples.
https://doi.org/10.1371/journal.pone.0215068.g003
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Another significant methodological contribution of this work is that, in an attempt to normal-
ize starting experimental conditions and strengthen the robustness of the obtained data, analy-
ses were conducted against a reference panel of well-characterize DNA samples. Our results
evidenced marked detection differences among tests depending on the targeted parasite spe-
cies considered, with diagnostic sensitivities typically ranging from 53–88% for Cryptosporid-
ium spp., and from 68–100% for G. duodenalis. The diagnostic sensitivity of these methods for
the detection of E. histolytica was not fully assessed due to the insufficient number of positive
samples to this pathogen available. Despite the highly variable sensitivity values observed, all
four methods did not cross-react with any of the DNA samples from other protozoan or hel-
minthic parasite species tested, suggesting a specificity near 100%. However, the exact extent
of this statement should be confirmed in future studies including a larger panel of DNA sam-
ples from other potentially cross-reacting enteric pathogen and commensal species including
Cyclospora cayetanensis, Entamoeba coli, Endolimax nana, Blastocystis sp., and Dientamoeba
fragilis.
Regarding Cryptosporidium detection, the R-Biopharm method achieved the best perfor-
mance in terms of diagnostic sensitivity (87.5%) and detection limit (two order of magnitude
superior to that of the other tests). In contrast, the Diagenode (diagnostic sensitivity: 75.0%)
and the Fast Track (diagnostic sensitivity: 53.1%) assays performed comparatively worse. This
finding is hardly surprising when considering that both methods at best equalled the diagnos-
tic performance of conventional microscopy when attempting to detect Cryptosporidium in
clinical samples [3,13]. However, the Fast Track method was much better suited for the detec-
tion of G. duodenalis than the other three assays evaluated here, achieving a 100% sensitivity
and a detection limit at least one order of magnitude superior to that of the other three meth-
ods. This is well in agreement with previous findings in patients with diarrhoea from commu-
nity or hospital sources, where the Fast Track assay detected 83% more G. duodenalis-infected
cases than microscopy examination [13]. In contrast, the Diagenode method achieved the low-
est diagnostic sensitivity (68.1%) for the identification of G. duodenalis of all four assays com-
pared here. This finding is also in line with previous data demonstrating that this technique
performs only moderately better than conventional microscopy during routine examination of
clinical stool samples [3,15]. Regarding E. histolytica, all methods tested, excepting Diagenode,
performed similarly well for the detection of E. histolytica, with the Fast Track assay providing
the highest diagnostic sensitivity values. However, these figures should be interpreted with
caution due to the comparatively low number of E. histolytica DNA samples available for the
analyses. Considering all the above, our data demonstrated large differences in the diagnostic
performance of the compared methods. In addition to the test sensitivity/specificity evaluated
here, other factors including cost, patient population surveyed, laboratory workflow, and diag-
nostic algorithm should be carefully considered when choosing the most appropriate multiplex
PCR platform for the simultaneous detection of Cryptosporidium spp., G. duodenalis, and E.
histolytica in human stool samples.
Our study has some limitations. First, the reference panel contained a restricted number of
DNA samples, particularly those positive to E. histolytica and to other intestinal pathogen and
commensal species. This fact may have hampered the accuracy of some of the obtained results.
In order to minimize this issue, statistical analyses were based on the Shapiro-Wilk’s test as
non-parametric test, a method particularly suited for small to moderate samples sizes. Other
potential confounding factors are the design of the primer sets used to amplify the selected tar-
gets and the use of different qPCR instruments depending on the method evaluated.
Accurate and fast detection of clinically relevant enteric protozoa is highly desirable for
prompt, adequate, and effective treatment [10]. In this context, multiplex qPCR platforms
have been reliably shown to increase the positivity rates of protozoan pathogens compared to
Commercial multiplex real-time PCR assays for the detection of diarrhoea-causing protozoa
PLOS ONE | https://doi.org/10.1371/journal.pone.0215068 April 8, 2019 8 / 11
conventional methods [13,22–24]. Even more importantly, multiplex molecular panels includ-
ing viral, bacterial, and parasitic pathogens enable the syndromic testing of patients with gas-
trointestinal symptoms in a cost-effective manner [25]. Taken together, these facts explain why
these methodologies are being increasingly used in diagnostic laboratories and reference cen-
tres. However, the choice of the most suitable assay should be based on a careful evaluation of
variable including optimal laboratory workflow and diagnostic algorithm, test performance,
and patient population to be tested.
Supporting information
S1 Table. Full dataset showing the characteristics of the DNA sample panel used, the initial
experimental conditions, and the diagnostic results obtained with each method compared
in the present study.
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